HE-4 A Novel Tumour Marker for Ovarian Mass and Its Comparison with CA 125
Authors:
- 3 May 2024
- journal article
- research article
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 22 (2) , 1-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Screening for Ovarian CancerJAMA, 2018
- Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancerVirchows Archiv, 2017
- HE4 Serum Levels Are Associated with Heart Failure Severity in Patients With Chronic Heart FailureJournal of Cardiac Failure, 2017
- Serum human epididymis protein 4 (HE4) may be a better tumor marker in early lung cancerClinica Chimica Acta, 2016
- HE4 in the differential diagnosis of ovarian massesClinica Chimica Acta, 2015
- Body mass index does not influence human epididymis protein 4 concentrations in serumClinica Chimica Acta, 2015
- Human epididymis protein 4: Factors of variationClinica Chimica Acta, 2015
- Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosisNature Medicine, 2013
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigmHuman Pathology, 2011
- Proteins with whey-acidic-protein motifs and cancerThe Lancet Oncology, 2006